Xingqi Eye Medicine: Net profit in the first half of 2025 increased by 97.75% year-on-year, intending to distribute a dividend of 7 yuan.

Xingqi Eye Medicine announced that in the first half of 2025, the operating income was 1.163 billion yuan, a year-on-year increase of 30.38%. The net profit was 335 million yuan, a year-on-year increase of 97.75%. It is planned to distribute a cash dividend of 7 yuan per 10 shares to all shareholders.